214 related articles for article (PubMed ID: 35778768)
21. Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren's syndrome.
van Woerkom JM; Kruize AA; Barendregt PJ; Kater L; Hené R; Bootsma H; Custers RJ; Jacobs JW; Bijlsma JW
Rheumatology (Oxford); 2006 Apr; 45(4):470-7. PubMed ID: 16287920
[TBL] [Abstract][Full Text] [Related]
22. The Diagnostic Performance of Early Sjögren's Syndrome Autoantibodies in Juvenile Sjögren's Syndrome: The University of Florida Pediatric Cohort Study.
Thatayatikom A; Jun I; Bhattacharyya I; Berg K; Lee YJ; Kim Y; Adewumi A; Zhang W; Thatayatikom S; Shah A; Beal C; Modica R; Elder ME; Cha S
Front Immunol; 2021; 12():704193. PubMed ID: 34249010
[TBL] [Abstract][Full Text] [Related]
23. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry.
Malladi AS; Sack KE; Shiboski SC; Shiboski CH; Baer AN; Banushree R; Dong Y; Helin P; Kirkham BW; Li M; Sugai S; Umehara H; Vivino FB; Vollenweider CF; Zhang W; Zhao Y; Greenspan JS; Daniels TE; Criswell LA
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):911-8. PubMed ID: 22238244
[TBL] [Abstract][Full Text] [Related]
24. Anti-Sjögren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature.
Mittal GK; Mittal S; Kaur H; Stephen SR; Sekhar S; Sureshbabu S; Sandhya P
Rheumatol Int; 2021 Oct; 41(10):1855-1866. PubMed ID: 33040168
[TBL] [Abstract][Full Text] [Related]
25. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and risk factors of neurological involvement in Sjögren's syndrome.
Ye W; Chen S; Huang X; Qin W; Zhang T; Zhu X; Zhu X; Lin C; Wang X
BMC Neurosci; 2018 Apr; 19(1):26. PubMed ID: 29703151
[TBL] [Abstract][Full Text] [Related]
27. Gynecological symptoms in primary and secondary Sjögren's syndrome and the effect of the disease on sexuality.
Ozdemir Isik O; Temiz Karadag D; Tekeoglu S; Yazici A; Cefle A
J Sex Med; 2024 Feb; 21(3):248-254. PubMed ID: 38366657
[TBL] [Abstract][Full Text] [Related]
28. Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin.
Tensing EK; Solovieva SA; Tervahartiala T; Nordström DC; Laine M; Niissalo S; Konttinen YT
Clin Exp Rheumatol; 2001; 19(3):313-6. PubMed ID: 11407086
[TBL] [Abstract][Full Text] [Related]
29. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
30. [Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjögren's syndrome].
Hofauer B; Bas M; Manour N; Knopf A
HNO; 2013 Nov; 61(11):921-7. PubMed ID: 23868654
[TBL] [Abstract][Full Text] [Related]
31. Minor salivary gland fibrosis in Sjögren's syndrome is elevated, associated with focus score and not solely a consequence of aging.
Leehan KM; Pezant NP; Rasmussen A; Grundahl K; Moore JS; Radfar L; Lewis DM; Stone DU; Lessard CJ; Rhodus NL; Segal BM; Scofield RH; Sivils KL; Montgomery C; Farris AD
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):80-88. PubMed ID: 29148407
[TBL] [Abstract][Full Text] [Related]
32. Serological profiles in subgroups of patients with Sjögren's syndrome.
Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
[TBL] [Abstract][Full Text] [Related]
34. "Dry oral and ocular manifestations and autoantibodies characteristic of primary Sjögren's syndrome in multiple sclerosis".
Hora JSI; da Silva MCR; Braga CLS; Loureiro AM; Alves ATNN; Lourenço SQC; Vasconcelos CCF
Mult Scler Relat Disord; 2022 Jun; 62():103783. PubMed ID: 35452962
[TBL] [Abstract][Full Text] [Related]
35. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study.
Andonopoulos AP; Drosos AA; Skopouli FN; Moutsopoulos HM
Clin Exp Rheumatol; 1989; 7(2):203-5. PubMed ID: 2736835
[TBL] [Abstract][Full Text] [Related]
36. Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.
Chen KS; Jiang MC; Li CJ; Liu OK; Tsai CS
J Int Med Res; 2009; 37(4):1088-96. PubMed ID: 19761691
[TBL] [Abstract][Full Text] [Related]
37. Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome.
Tashbayev B; Rusthen S; Young A; Herlofson BB; Hove LH; Singh PB; Rykke M; Aqrawi LA; Chen X; Utheim ØA; Utheim TP; Palm Ø; Jensen JL
Sci Rep; 2017 Sep; 7(1):10761. PubMed ID: 28883442
[TBL] [Abstract][Full Text] [Related]
38. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
[TBL] [Abstract][Full Text] [Related]
39. Baseline disease activity influences subsequent achievement of patient acceptable symptom state in Sjögren's syndrome.
Park EH; Ha YJ; Kang EH; Song YW; Scofield RH; Lee YJ
Rheumatology (Oxford); 2021 Jun; 60(6):2714-2724. PubMed ID: 33188390
[TBL] [Abstract][Full Text] [Related]
40. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
Brito-Zerón P; Ramos-Casals M;
Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
